A new review from CCFRA (Bioinformatics
: a review of current and future applications in the food industry--Review 59) explains what bioinformatics
is and its potentially pivotal future role in the food and drink industry.
analyses, like logo analysis, may prove useful in obtaining further data from the large M.
In 2001, the market for bioinformatic
software, which includes data mining and visualization tools, totaled about $250 million.
Thomas Reynolds, Executive Vice President of Science and Technology and the Scientific Director for the new program, "This new contract recognizes the expertise and experience of AI BioTech and its industry partner in performing DNA sequence analysis of complex genomes and in creating the bioinformatic
background necessary to process all the resulting data.
Through this collaborative research agreement with QBI, Shionogi aims to develop pharmaceutical and diagnostic agents for osteoarthritis, and also expects to obtain significant knowledge and experience in genomic technology related to drug discovery research, such as disease-related gene searching and bioinformatics
Case 3: Application of Bioinformatic
Tools to Identify Potential Allergens
and Functional Genomics Jonathan Pevsner Hoboken, NJ:John Wiley & Sons, 2003.
In addition to the Gene Expression Profiling Service, Asuragen also offers Custom RNA isolation, microRNA expression profiling, and bioinformatics
services to support and accelerate your research.
More recently, advances in analytical separation and detection technologies, coupled with developments in bioinformatics
, have made it possible to measure and interpret complex time-related metabolite profiles that are present in biofluids such as urine, plasma, saliva, and cerebrospinal fluid.
The Celera Genomics Group is focused on discovery, development, and commercialization of diagnostic products as well as leveraging its proteomic, bioinformatic
, and genomic capabilities to identify and validate drug targets, and is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders.
We look at BiTmaP as a source of bioinformatic
talent, and have encouraged corporations in the nearby research park to do the same.
This section of the report provides an in depth view into the bioinformatic
deals and alliances announced in 2005, in a clear and accessible format.